EHDN virtual platform meeting: Tominersen – GenHD1 data and beyond
…The conference will consist of a presentation by the sponsor, Roche, followed by a Q&A session and a discussion by a panel on open (and answered) questions and the way… […]
…The conference will consist of a presentation by the sponsor, Roche, followed by a Q&A session and a discussion by a panel on open (and answered) questions and the way… […]
…informal settings. All EHDN plenary sessions are open to clinicians, scientists, EHA delegates and members of families affected by HD. In intermedite years a remote meeting is being held, to… […]
…Registration and abstract submission for EHDN2018, taking place in Vienna from September 14-16, are now open. For all details and registering, click here… […]
The comment period for the amendments to the EHDN Constitution is now open. […]
…on the basis of protocol review and discussion by the EHDN Executive Committee following recommendations from the independent EHDN Scientific and Bioethical Advisory Committee. Trial protocol endorsement should not be… […]
…decision is made on the basis of protocol review and discussion by the EHDN Executive Committee following recommendations from the independent EHDN Scientific and Bioethical Advisory Committee. Trial protocol endorsement… […]
…registration. *EHDN endorsement: The EHDN endorses protocols it finds to be of a high scientific and ethical quality. The endorsement decision is made on the basis of protocol review and… […]
…a high scientific and ethical quality. The endorsement decision is made on the basis of protocol review and discussion by the EHDN Executive Committee following recommendations from the independent EHDN… […]
…as its co-chair from 2020 to 2022, and as its chair from 2022 onwards. In addition, I am a member of the ‘Clinical Trials Review Committee’ and was part of… […]
…basis of protocol review and discussion by the EHDN Executive Committee following recommendations from the independent EHDN Scientific and Bioethical Advisory Committee. Trial protocol endorsement should not be viewed as… […]